Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Mayur Ramesh

9PUBLICATIONS
48CO-AUTHORS
Major global burdens of diseaseImmunogenetics (incl. genetic immunology)Disease surveillanceApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

Sort by Publication Date:
|Jul 25, 2025
Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults With Respiratory Syncytial Virus.

Kevin C Ma, Diya Surie, Yuwei Zhu

|Apr 08, 2025
Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024.

Nathaniel M Lewis, Elizabeth J Harker, Seana Cleary

|Nov 28, 2024
Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study.

Nathaniel M Lewis, Elizabeth J Harker, Lauren B Grant

|May 03, 2024
Impact of time to treatment in first occurrence, non-severe <i>Clostridioides difficile</i> infection for elderly patients: are we waiting too long to treat?

Rhett Vandervelde, Mark E Mlynarek, Mayur Ramesh

|Dec 05, 2023
Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023.

Nathaniel M Lewis, Yuwei Zhu, Ithan D Peltan

|Jul 21, 2022
Real-world Experience of Sotrovimab in High-risk, Immunocompromised COVID-19 Patients.

Navina K Birk, Saniya Jain, Louis Massoud

Pageof 2

Frequent Collaborators

4 joint publications

Nathaniel M Lewis

4 joint publications

Shekhar Ghamande

4 joint publications

Basmah Safdar

3 joint publications

Joseph Miller

3 joint publications

Manjusha Gaglani

3 joint publications

David N Hager

3 joint publications

Ithan D Peltan

3 joint publications

Amira Mohamed

3 joint publications

Yuwei Zhu

3 joint publications

Akram Khan

Frequent Collaborators

4 joint publications

Nathaniel M Lewis

4 joint publications

Shekhar Ghamande

4 joint publications

Basmah Safdar

3 joint publications

Joseph Miller

Top Related Videos

An <em>In vitro</em> Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An <em>In vitro</em> Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on : Dec 10, 2013

8.0K
An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on : Dec 01, 2017

35.7K
Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on : Apr 15, 2017

17.8K
See more related videos

Top Related Videos

An <em>In vitro</em> Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An <em>In vitro</em> Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on : Dec 10, 2013

8.0K
An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on : Dec 01, 2017

35.7K
Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on : Apr 15, 2017

17.8K
See more related videos